Cost of revenue · 2019–2025

Universe Pharmaceuticals cost of revenue

$11.6B−31.8% · FY2025

Universe Pharmaceuticals (UPC) reported $11.6B in cost of revenue for fiscal 2025, −31.8% year on year.

$19.8M2019$16.6M2020$22.7M2021$18.3M2022$22.0B2023$17.0B2024$11.6B2025
Universe Pharmaceuticals — Cost of revenue, 2019–2025
Fiscal yearCost of revenueChangeFiling
FY20252025-09-30$11.6B−31.8%Open →
FY20242024-09-30$17.0B−22.9%Open →
FY20232023-09-30$22.0B+120,400.9%Open →
FY20222022-09-30$18.3M−19.4%Open →
FY20212021-09-30$22.7M+36.4%Open →
FY20202020-09-30$16.6M−16.2%Open →
FY20192019-09-30$19.8M—Open →

Cost of revenue — Cost of revenue is the direct cost of producing what the company sold — materials, manufacturing and the labour tied to delivery. It excludes sales, marketing and administration. Revenue minus this figure is gross profit.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth +189.0%

Cost of revenue at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Universe Pharmaceuticals cost of revenue |url=https://companiesranked.com/en/company/universe-pharmaceuticals/cost-of-revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Universe Pharmaceuticals cost of revenue. CompaniesRanked. https://companiesranked.com/en/company/universe-pharmaceuticals/cost-of-revenue

BibTeX

@misc{companiesranked-en-company-universe-pharmaceuticals-cost-of-revenue-2026,
  author       = {{CompaniesRanked}},
  title        = {{Universe Pharmaceuticals cost of revenue}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/universe-pharmaceuticals/cost-of-revenue}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 20-F · 0001213900-26-009000 · January 29, 2026

{{cite web |title=Universe Pharmaceuticals cost of revenue — 20-F (0001213900-26-009000) |url=https://www.sec.gov/Archives/edgar/data/1809616/000121390026009000/ea0273969-20f_universe.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-01-29}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Universe Pharmaceuticals overview